SPHK1 and atopic eczema: Here, we conducted a clinical trial to evaluate the efficacy of a multi-lamellar emulsion (MLE) containing the pseudoceramide PC-9S and a synthetic sphingosine kinase 1 (SPHK1) activator, DefensamideTM, in improving mild-to-moderate atopic dermatitis.